Breath Condensate of Lung Cancer Patients and Healthy Controls to Measure RNA Species in Exhaled Breath Condensate

Overview

About this study

The purpose of this study is to develop tests for early detection of lung cancer (LC) based on multiomics analyses of patients’ breath condensates.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

In the Lung Cancer group, any patient of 18 years or older with lung cancer.
In the control group, any 18 year or older volunteer with no history of Lung Cancer.

Exclusion Criteria:

Anyone with a history of lung disease, such as emphysema. Also, anyone with a history of cancer except Lung Cancer in the experimental group.

Eligibility last updated 7/15/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Farhad Kosari, Ph.D.	Open for enrollment	Contact information: Brandon Clapp (507) 284-2122 Clapp.Brandon@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Farhad Kosari, Ph.D.

Open for enrollment

Contact information:

Brandon Clapp

(507) 284-2122

Clapp.Brandon@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials